APA

Bounameaux H., Banga J. D., Bluhmki E., Coccheri S., Fiessinger J. N., Haarmann W., Lockner D., Mahler F., Ninet J. & Schneider P. A. (19920828). Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. : Thrombosis and haemostasis.

Chicago

Bounameaux H, Banga J D, Bluhmki E, Coccheri S, Fiessinger J N, Haarmann W, Lockner D, Mahler F, Ninet J and Schneider P A. 19920828. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. : Thrombosis and haemostasis.

Harvard

Bounameaux H., Banga J. D., Bluhmki E., Coccheri S., Fiessinger J. N., Haarmann W., Lockner D., Mahler F., Ninet J. and Schneider P. A. (19920828). Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. : Thrombosis and haemostasis.

MLA

Bounameaux H, Banga J D, Bluhmki E, Coccheri S, Fiessinger J N, Haarmann W, Lockner D, Mahler F, Ninet J and Schneider P A. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. : Thrombosis and haemostasis. 19920828.